SEC Form 4 · accession 0001628280-26-062915
Amneal Pharmaceuticals, Inc. · AMRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
J Kevin Buchi
Director
Period of report
Sep 17, 2026
Accepted (ET)
Sep 21, 2026 · 4:33 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001723128
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1 | Sep 17, 2026 | G | 20,445 | $0.00 | D | 75,077 | D | |
| Class A Common StockF1 | holding | — | — | — | 113,944 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On September 17th, the reporting person transferred 20,445 shares of Class A Common Stock to a trust for no consideration. The Reporting person is trustee of the trust.